The carrying amount of the Group’s assets decreased by €(2,262) million to €11,984 million during 2022, mainly due to the impairment of goodwill and other intangible assets (€(1,722) million), the depreciation and amortisation (€(300) million), the decrease in cash and cash equivalents (€(161) million), the sale of the assets that were presented as held for sale as of 31 December 2021 (€(115) million), the decrease in deferred tax assets (€(149) million) and the share of profit (loss) of joint ventures and associates (€(121) million). These were partially offset by CAPEX (€89 million), the increase in receivables related to the sales of subsidiaries (€60 million) and by the exchange gain in the period driven by the appreciation of the exchange rate of the BRL against the EUR, increasing both the investments in joint ventures and associates (€39 million) and the value in EUR of the loan in BRL (increase of €20 million) granted by Adevinta Finance AS to Bom Negócio Atividades de Internet Ltda (OLX Brazil joint venture). Also contributing was the interest accrued in relation to this loan (€24 million) as well as the increase in fair value of the crosscurrency interest rate swap contracts due to USD appreciation versus EUR (€49 million).
The carrying amount of the Group’s liabilities decreased by €(425) million to €3,436 million during 2022, mainly due to the repayment of the multicurrency revolving facility (€(150) million) and the repayment of the EUR Term Loan B (€(165) million) as well as a decrease in deferred tax liabilities (€(140) million), mainly due to amortisation of intangible assets and impairment of intangible assets, that was partly offset by the increase in the USD TLB due to the exchange rate of the USD against the EUR (€27 million).
The Group’s equity ratio was 71% as at 31 December 2022, compared to 73% as at 31 December 2021.
The Group had at 31 December 2022 net interest-bearing debt of €2,199 million and €520 million total liquidity available. Management considers Adevinta’s liquidity and refinancing risk to be acceptable considering the cash generation projections as well as the cash conversion rate of the business.
Net cash flow from operating activities was €352 million for the year, compared to €193 million in 2021. The increase is primarily related to the increase in gross operating profit as well as a decrease in tax payments being partially compensated by a negative impact from DST payments in France amounting to €(33) million, including €(22) million in respect of DST for prior years, and increased integration and interest expenses. Net cash flow from investing activities was €(92) million for the year, compared to €(1,983) million in 2021. Although in 2022 the investment in development and purchase of intangible assets and property, plant and equipment in other shares has increased compared to 2021, the decrease in cash outflow is mainly due to the cash consideration paid for the eCG acquisition (net of cash acquired) partly offset by proceeds received from disposal of subsidiaries (net of cash sold) in 2021 being much higher. Net cash flow from financing activities was €(429) million for the year, compared to €1,898 million in 2021. The decrease is primarily related to the repayments of interest-bearing loans and borrowings during 2022, whereas in 2021 there was an increase due to the cash received from the new financing obtained in 2021 related to the eCG acquisition. Other movements were the acquisition of treasury shares to meet the long-term incentive obligations for 2022 and 2021 (10,000,000 and 1,700,000 treasury shares respectively).